IL17A and diabetes mellitus: Furthermore, joint pathway analysis further confirmed that the AGE-RAGE signalling pathway, the TNF signalling pathway, and the IL-17 signalling pathway are also key mechanisms mediating the hypoglycaemic efficacy of AR in diabetes and its complications.